Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topoisomerase 2 Expression and Acute Myeloid Leukemia (AML)

NCT01059734 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT01059734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01059734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topoisomerase 2 Expression and Acute Myeloid Leukemia (AML)
Lead sponsor
SWOG Cancer Research Network
Phase
Observational
Overall status
Completed
Start date
June 30, 2010
Completion date
June 30, 2012
Enrollment
357 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia